Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 8/2019

Open Access 01-08-2019 | Necrotizing Fasciitis | Original Article

The prevalence of methicillin-resistant Staphylococcus aureus among diabetic patients: a meta-analysis

Authors: Helen J. Stacey, Caitlin S. Clements, Susan C. Welburn, Joshua D. Jones

Published in: Acta Diabetologica | Issue 8/2019

Login to get access

Abstract

Aims

Diabetic patients have multiple risk factors for colonisation with methicillin-resistant Staphylococcus aureus (MRSA), a nosocomial pathogen associated with significant morbidity and mortality. This meta-analysis was conducted to estimate the prevalence of MRSA among diabetic patients.

Methods

The MEDLINE, Embase, BIOSIS, and Web of Science databases were searched for studies published up to May 2018 that reported primary data on the prevalence of MRSA in 10 or more diabetic patients. Two authors independently assessed study eligibility and extracted the data. The main outcomes were the pooled prevalence rates of MRSA colonisation and infection among diabetic populations.

Results

Eligible data sets were divided into three groups containing data about the prevalence of MRSA colonisation or in diabetic foot or other infections. From 23 data sets, the prevalence of MRSA colonisation among 11577 diabetics was 9.20% (95% CI, 6.26–12.63%). Comparison of data from 14 studies that examined diabetic and non-diabetic patients found that diabetics had a 4.75% greater colonisation rate (P < 0.0001). From 41 data sets, the prevalence of MRSA in 10994 diabetic foot infection patients was 16.78% (95% CI, 13.21–20.68%). Among 2147 non-foot skin and soft-tissue infections, the MRSA prevalence rate was 18.03% (95% CI, 6.64–33.41).

Conclusions

The prevalence of MRSA colonisation among diabetic patients is often higher than among non-diabetics; this may make targeted screening attractive. In the UK, many diabetic patients may already be covered by the current screening policies. The prevalence and impact of MRSA among diabetic healthcare workers requires further research. The high prevalence of MRSA among diabetic foot infections may have implications for antimicrobial resistance, and should encourage strategies aimed at infection prevention or alternative therapies.
Appendix
Available only for authorised users
Literature
1.
Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36(1):53–59CrossRefPubMed
2.
Filice GA, Nyman JA, Lexau C, Lees CH, Bockstedt LA, Como-Sabetti K et al (2010) excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infect Control Hosp Epidemiol 31(04):365–373CrossRefPubMed
3.
Hidron AI, Kourbatova EV, Halvosa JS, Terrell BJ, McDougal LK, Tenover FC et al (2005) Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA Nasal Carriage. Clin Infect Dis 41(2):159–166
4.
Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR (2004) Methicillin-Resistant Staphylococcus aureus (MRSA) Nares Colonization at Hospital Admission and Its Effect on Subsequent MRSA Infection. Clin Infect Dis 39(6):776–782CrossRefPubMed
5.
Zacharioudakis IM, Zervou FN, Ziakas PD, Mylonakis E (2014) Meta-analysis of methicillin-resistant Staphylococcus aureus colonization and risk of infection in dialysis patients. J Am Soc Nephrol JASN 25(9):2131–2141CrossRefPubMed
6.
Zervou FN, Zacharioudakis IM, Ziakas PD, Rich JD, Mylonakis E (2014) Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization in HIV infection: a meta-analysis. Clin Infect Dis Off Publ Infect Dis Soc Am 59(9):1302–1311CrossRef
7.
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103(1):137–149CrossRefPubMed
8.
9.
10.
Eleftheriadou I, Tentolouris N, Argiana V, Jude E, Boulton AJ (2010) Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs 70(14):1785–1797CrossRefPubMed
11.
Zervou FN, Zacharioudakis IM, Ziakas PD, Mylonakis E (2014) MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis. Pediatrics 133(4):e1015–e1023CrossRefPubMed
12.
Ziakas PD, Anagnostou T, Mylonakis E (2014) The prevalence and significance of methicillin-resistant Staphylococcus aureus colonization at admission in the general ICU Setting: a meta-analysis of published studies. Crit Care Med 42(2):433–444CrossRefPubMed
13.
Gleeson A, Larkin P, Walsh C, O’Sullivan N (2016) Methicillin-resistant Staphylococcus aureus: Prevalence, incidence, risk factors, and effects on survival of patients in a specialist palliative care unit: A prospective observational study. Palliat Med 30(4):374–381CrossRefPubMed
14.
Cheng N-C, Tai H-C, Chang S-C, Chang C-H, Lai H-S. Necrotizing fasciitis in patients with diabetes mellitus: clinical characteristics and risk factors for mortality. BMC Infect Dis. 2015;15(417)
15.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 19(15):2008–2012CrossRef
16.
17.
18.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
19.
20.
Legese H, Kahsay AG, Kahsay A, Araya T, Adhanom G, Muthupandian S et al (2018) Nasal carriage, risk factors and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus among healthcare workers in Adigrat and Wukro hospitals, Tigray, Northern Ethiopia. BMC Res Notes 11(1):250CrossRefPubMedPubMedCentral
21.
Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE et al (2008) Changes in the Prevalence of Nasal Colonization with Staphylococcus aureus in the United States, 2001–2004. J Infect Dis 197(9):1226–1234CrossRefPubMed
22.
Daeschlein G, Assadian O, Rangous I, Kramer A (2006) Risk factors for Staphylococcus aureus nasal carriage in residents of three nursing homes in Germany. J Hosp Infect 63(2):216–220CrossRefPubMed
23.
Daeschlein G, Podewils S von, Bloom T, Assadian O, Napp M, Haase H et al (2015) Risk factors for MRSA colonization in dermatologic patients in Germany. JDDG J Dtsch Dermatol Ges 13(10):1015–1022PubMed
24.
Gupta K, Martinello RA, Young M, Strymish J, Cho K, Lawler E (2013) MRSA nasal carriage patterns and the subsequent risk of conversion between patterns, infection, and death. PLOS One 10(1):e53674CrossRef
25.
Haleem A, Schultz JS, Heilmann KP, Dohrn CL, Diekema DJ, Gardner SE (2014) Concordance of nasal and diabetic foot ulcer staphylococcal colonization. Diagn Microbiol Infect Dis 79(1):85–89CrossRefPubMedPubMedCentral
26.
Hart J, Hamilton EJ, Makepeace A, Davis WA, Latkovic E, Lim EM et al (2015) Prevalence, risk factors and sequelae of Staphylococcus aureus carriage in diabetes: the Fremantle Diabetes Study Phase II. J Diabetes Complications 29(8):1092–1097CrossRefPubMed
27.
Jayarani K, Sundarji SS (2015) Detection of MRSA from nasal carrier among diabetic foot ulcer patients in Tertiary Care Hospital Puducherry. Int J Pharma Bio Sci 6(3):B618–B623
28.
Karadag-Oncel E, Gonc N, Altay O, Cengiz AB, Ozon A, Pinar A et al (2015) Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus in children with diabetes mellitus: Trends between 2005 and 2013. Am J Infect Control 43(9):1015–1017CrossRefPubMed
29.
Kutlu SS, Cevahir N, Akalin S, Akin F, Dirgen Caylak S, Bastemir M et al (2012) Prevalence and risk factors for methicillin-resistant Staphylococcus aureus colonization in a diabetic outpatient population: a prospective cohort study. Am J Infect Control 40(4):365–368CrossRefPubMed
30.
Lin J, Xu P, Peng Y, Lin D, Ou Q, Zhang T et al (2017) Prevalence and characteristics of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus nasal colonization among a community-based diabetes population in Foshan, China. J Diabetes Investig 8(3):383–391CrossRefPubMed
31.
Lu S-Y, Chang F-Y, Cheng C-C, Lee K-D, Huang Y-C (2011) Methicillin-resistant Staphylococcus aureus nasal colonization among adult patients visiting emergency department in a medical center in Taiwan. PloS One 6(6):e18620CrossRefPubMedPubMedCentral
32.
Saxena AK, Panhotra BR, Venkateshappa CK, Sundaram DS, Naguib M, Uzzaman W et al (2002) The impact of nasal carriage of methicillin-resistant and methicillin-susceptible Staphylococcus a ureus (MRSA & MSSA) on vascular access-related septicemia among patients with type-II diabetes on dialysis. Ren Fail 24(6):763–777CrossRefPubMed
33.
Schechter-Perkins EM, Mitchell PM, Murray KA, Rubin-Smith JE, Weir S, Gupta K (2011) Prevalence and predictors of nasal and extranasal staphylococcal colonization in patients presenting to the emergency department. Ann Emerg Med 57(5):492–499CrossRefPubMed
34.
Torres K, Sampathkumar P (2013 Nov) Predictors of methicillin-resistant Staphylococcus aureus colonization at hospital admission. Am J Infect Control 41(11):1043–1047CrossRefPubMed
35.
Yeoh LY, Tan FLG, Willis GC, Ooi ST (2014) Methicillin-resistant Staphylococcus aureus carriage in hospitalized chronic hemodialysis patients and its predisposing factors. Hemodial Int Int Symp Home Hemodial 18(1):142–147CrossRef
36.
Baum H von, Schmidt C, Svoboda D, Bock-Hensley O, Wendt C (2002) Risk factors for methicillin-resistant Staphylococcus aureus carriage in residents of german nursing homes. Infect Control Hosp Epidemiol 23(9):511–515CrossRef
37.
Kao K-C, Chen C-B, Hu H-C, Chang H-C, Huang C-C, Huang Y-C (2015) Risk factors of methicillin-resistant Staphylococcus aureus infection and correlation with nasal colonization based on molecular genotyping in medical intensive care units: a prospective observational study. Medicine (Baltimore) 94(28):e1100CrossRef
38.
Garazi M, Edwards B, Caccavale D, Auerbach C, Wolf-Klein G (2009) Nursing homes as reservoirs of MRSA: myth or reality? J Am Med Dir Assoc 10(6):414–418CrossRefPubMed
39.
40.
Dunyach-Remy C, Courtais-Coulon C, DeMattei C, Jourdan N, Schuldiner S, Sultan A et a (2017) Link between nasal carriage of Staphylococcus aureus and infected diabetic foot ulcers. Diabetes Metab 43(2):167–71CrossRefPubMed
41.
Stanaway S, Johnson D, Moulik P, Gill G (2007) Methicillin-resistant Staphyloccocus aureus (MRSA) isolation from diabetic foot ulcers correlates with nasal MRSA carriage. Diabetes Res Clin Pract 75(1):47–50CrossRefPubMed
42.
Acharya S, Soliman M, Egun A, Rajbhandari SM (2013) Conservative management of diabetic foot osteomyelitis. Diabetes Res Clin Pract 101(3):e18–e20CrossRefPubMed
43.
Ahmed EF, Gad GFM, Abdalla AM, Hasaneen AM, Abdelwahab SF (2014) Prevalence of methicillin resistant Staphylococcus aureus among Egyptian patients after surgical interventions. Surg Infect 9(4):404–411CrossRef
44.
Aragón-Sánchez FJ, Cabrera-Galván JJ, Quintana-Marrero Y, Hernández-Herrero MJ, Lázaro-Martínez JL, García-Morales E et al (2008) Outcomes of surgical treatment of diabetic foot osteomyelitis: a series of 185 patients with histopathological confirmation of bone involvement. Diabetologia 51(11):1962CrossRefPubMed
45.
Bravo-Molina A, Linares-Palomino JP, Lozano-Alonso S, Asensio-García R, Ros-Díe E, Hernández-Quero J (2016) Influence of wound scores and microbiology on the outcome of the diabetic foot syndrome. J Diabetes Complicat 30(2):329–334CrossRef
46.
Cervantes-García E, García-González R, Reséndiz-Albor A, Salazar-Schettino PM (2015) Infections of diabetic foot ulcers with methicillin-resistant Staphylococcus aureus. Int J Low Extrem Wounds 14(1):44–49CrossRefPubMed
47.
Citron DM, Goldstein EJC, Merriam CV, Lipsky BA, Abramson MA (2007) Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 45(9):2819–2828CrossRefPubMedPubMedCentral
48.
Commons RJ, Robinson CH, Gawler D, Davis JS, Price RN (2015) High burden of diabetic foot infections in the top end of Australia: an emerging health crisis (DEFINE study). Diabetes Res Clin Pract 110(2):147–157CrossRefPubMedPubMedCentral
49.
Dang CN, Prasad YDM, Boulton AJM, Jude EB (2003) Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 20(2):159–161CrossRefPubMed
50.
Djahmi N, Messad N, Nedjai S, Moussaoui A, Mazouz D, Richard J-L et al (2013) Molecular epidemiology of Staphylococcus aureus strains isolated from inpatients with infected diabetic foot ulcers in an Algerian University Hospital. Clin Microbiol Infect 19(9):E398–E404CrossRefPubMed
51.
El-Tahawy AT (2000) Bacteriology of diabetic foot infections. Saudi Med J 21(4):344–347PubMed
52.
Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R (2006) A clinico-microbiological study of diabetic foot ulcers in an indian tertiary care hospital. Diabetes Care 29(8):1727–1732CrossRefPubMed
53.
Galkowska H, Podbielska A, Olszewski WL, Stelmach E, Luczak M, Rosinski G et al (2009) Epidemiology and prevalence of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in patients with diabetic foot ulcers: focus on the differences between species isolated from individuals with ischemic vs. neuropathic foot ulcers. Diabetes Res Clin Pract 84(2):187–193CrossRefPubMed
54.
Ge Y, MacDonald H, Hait H, Lipsky B, Zasloff M, Holroyd K (2002) Microbiological profile of infected diabetic foot ulcers. Diabet Med 19(12):1032–1034CrossRefPubMed
55.
Goldstein EJC, Citron DM, Nesbit CA (1996) Diabetic foot infections: bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. Diabetes Care 19(6):638–641CrossRefPubMed
56.
Hartemann-Heurtier A, Robert J, Jacqueminet S, Van GH, Golmard JL, Jarlier V et al (2004) Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabet Med 21(7):710–715CrossRefPubMed
57.
Tentolouris N, Jude EB, Smirnof I, Knowles EA, Boulton AJM (1999) Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med 16(1):767–771CrossRefPubMed
58.
Lavery LA, Fontaine JL, Bhavan K, Kim PJ, Williams JR, Hunt NA (2014) Risk factors for methicillin-resistant Staphylococcus aureus in diabetic foot infections. Diabet Foot Ankle 5:3402CrossRef
59.
Lipsky BA, Stoutenburgh U (2005) Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections. J Antimicrob Chemother 55(2):240–245CrossRefPubMed
60.
Lipsky BA, Tabak YP, Johannes RS, Vo L, Hyde L, Weigelt JA (2010) Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia 53(5):914–923CrossRefPubMed
61.
Mendes JJ, Marques-Costa A, Vilela C, Neves J, Candeias N, Cavaco-Silva P et al (2012) Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diabetes Res Clin Pract 95(1):153–161CrossRefPubMed
62.
Nather A, Bee CS, Huak CY, Chew JLL, Lin CB, Neo S et al (2008) Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complicat 22(2):77–82CrossRef
63.
Reveles KR, Duhon BM, Moore RJ, Hand EO, Howell CK (2016) Epidemiology of methicillin-resistant Staphylococcus aureus diabetic foot infections in a large academic hospital: implications for antimicrobial stewardship. PLOS One 24(8):e0161658CrossRef
64.
Saltoglu N, Yemisen M, Ergonul O, Kadanali A, Karagoz G, Batirel A et al (2015) Predictors for limb loss among patient with diabetic foot infections: an observational retrospective multicentric study in Turkey. Clin Microbiol Infect 21(7):659–664CrossRefPubMed
65.
Shah M, Shoaib M, Razaq A, Ashraf M, Ahmad W (2017) Frequency of methicillin resistant Staphylococcus aureus in diabetic foot infections. Med Forum Mon 28(9):17–21
66.
Shankar EM, Mohan V, Premalatha G, Srinivasan RS, Usha AR (2005) Bacterial etiology of diabetic foot infections in South India. Eur J Intern Med 16(1):567–570CrossRefPubMed
67.
Sharma VK, Khadka PB, Joshi A, Sharma R (2006) Common pathogens isolated in diabetic foot infection in Bir Hospital. Kathmandu Univ Med J 4(15):295–301
68.
Shettigar K, Jain S, Bhat DV, Acharya R, Ramachandra L, Satyamoorthy K et al (2016) Virulence determinants in clinical Staphylococcus aureus from monomicrobial and polymicrobial infections of diabetic foot ulcers. J Med Microbiol 65(12):1392–1404CrossRefPubMed
69.
Tascini C, Piaggesi A, Tagliaferri E, Iacopi E, Fondelli S, Tedeschi A et al (2011) Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy. Diabetes Res Clin Pract 94(1):133–139CrossRefPubMed
70.
van Asten SAV, Mithani M, Peters EJG, La Fontaine J, Kim PJ, Lavery LA (2018) Complications during the treatment of diabetic foot osteomyelitis. Diabetes Res Clin Pract 1:58–64CrossRef
71.
Víquez-Molina G, Aragón-Sánchez J, Pérez-Corrales C, Murillo-Vargas C, López-Valverde ME, Lipsky BA (2018) Virulence factor genes in Staphylococcus aureus isolated from diabetic foot soft tissue and bone infections. Int J Low Extrem Wounds 17(1):36–41CrossRefPubMed
72.
Wang S-H, Sun Z-L, Guo Y-J, Yang B-Q, Yuan Y, Wei Q et al (2010) Meticillin-resistant Staphylococcus aureus isolated from foot ulcers in diabetic patients in a Chinese care hospital: risk factors for infection and prevalence. J Med Microbiol 59(10):1219–1224CrossRefPubMed
73.
Wu W, Liu D, Wang Y, Wang C, Yang C, Liu X et al (2017) Empirical antibiotic treatment in diabetic foot infection: a study focusing on the culture and antibiotic sensitivity in a population from Southern China. Int J Low Extrem Wounds 16(3):173–182CrossRefPubMed
74.
Ashong CN, Raheem SA, Hunter AS, Mindru C, Barshes NR (2016) Methicillin-resistant Staphylococcus aureus in foot osteomyelitis. Surg Infect 29(2):143–148CrossRef
75.
Henig O, Pogue JM, Cha R, Kilgore PE, Hayat U, Ja’ara M et al (2018) epidemiology of diabetic foot infection in the metro-detroit area with a focus on independent predictors for pathogens resistant to recommended empiric antimicrobial therapy. Open Forum Infect Dis 27:11
76.
Sotto A, Lina G, Richard J-L, Combescure C, Bourg G, Vidal L et al (2008) Virulence potential of Staphylococcus aureus strains isolated from diabetic foot ulcers. Diabetes Care 31(12):2318–2324CrossRefPubMedPubMedCentral
77.
Lipsky BA, Cannon CM, Ramani A, Jandourek A, Calmaggi A, Friedland HD et al (2015) Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience. Diabetes Metab Res Rev 31(4):395–401CrossRefPubMed
78.
Richard J-L, Sotto A, Jourdan N, Combescure C, Vannereau D, Rodier M et al (2008) Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers. Diabetes Metab 34:363–369CrossRefPubMed
79.
Changchien C-H, Chen Y-Y, Chen S-W, Chen W-L, Tsay J-G, Chu C (2011) Retrospective study of necrotizing fasciitis and characterization of its associated Methicillin-resistant Staphylococcus aureus in Taiwan. BMC Infect Dis 31:297CrossRef
80.
Fowler JR, Ilyas AM (2013) Epidemiology of adult acute hand infections at an urban medical center. J Hand Surg 1(6):1189–1193CrossRef
81.
Lipsky BA, Itani KMF, Weigelt JA, Joseph W, Paap CM, Reisman A et al (2011) The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials. Int J Infect Dis IJID Off Publ Int Soc Infect Dis 15(2):e140–e146
82.
Parriott AM, Arah OA (2013) Diabetes and early postpartum methicillin-resistant Staphylococcus aureus infection in US hospitals. Am J Infect Control 41(7):576–580CrossRefPubMed
83.
Raju S, Oli AK, Patil SA, Chandrakanth RK (2010) Prevalence of multidrug-resistant Staphylococcus aureus in diabetics clinical samples. World J Microbiol Biotechnol 1(1):171CrossRef
84.
85.
Hennessy SA, Shah PM, Guidry CA, Davies SW, Hranjec T, Sawyer RG (2015) Can Nasal Methicillin-resistant Staphylococcus aureus Screening Be Used to Avoid Empiric Vancomycin Use in Intra-Abdominal Infection? Surg Infect 16(4):396–400
86.
McKinnell JA, Miller LG, Eells SJ, Cui E, Huang SS (2013) A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol 34(10):1077–1086CrossRefPubMed
87.
Yamasaki F, Takeuchi S, Uehara Y, Matsushita M, Arise K, Morimoto N et al (2018) Prevalence and characteristics of methicillin-resistant Staphylococcus aureus in community residents of Japan. J Gen Fam Med 9(3):77–81CrossRef
88.
Lin J, Peng Y, Xu P, Zhang T, Bai C, Lin D et al (2016) Methicillin-resistant Staphylococcus aureus nasal colonization in chinese children: a prevalence meta-analysis and review of influencing factors. PloS One 11(7):e0159728CrossRefPubMedPubMedCentral
89.
den Heijer CD, van Bijnen EM, Paget WJ, Pringle M, Goossens H, Bruggeman CA et al (2013) Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study. Lancet Infect Dis 13(5):409–415CrossRef
90.
91.
Holtfreter S, Grumann D, Balau V, Barwich A, Kolata J, Goehler A et al (2016) Molecular epidemiology of Staphylococcus aureus in the general population in northeast germany: results of the study of health in pomerania (SHIP-TREND-0). J Clin Microbiol 54(11):2774–2785CrossRefPubMedPubMedCentral
92.
Karas JA, Enoch DA, Eagle HJ, Emery MM. Random meticillin-resistant Staphylococcus aureus carrier surveillance at a district hospital and the impact of interventions to reduce endemic carriage. J Hosp Infect. 2009 Apr 1;71(4):327–32
93.
Reilly JS, Stewart S, Christie P, Allardice G, Smith A, Masterton R et al (2010) Universal screening for meticillin-resistant Staphylococcus aureus: interim results from the NHS Scotland pathfinder project. J Hosp Infect. 74(1):35–41
94.
Barkatali M, Heywood N, White R, Paton R (2013) MRSA screening in orthopaedic surgery: Clinically valuable and cost effective? Acta Orthop Belg 79(4):463–469PubMed
95.
Dave J, Jenkins PJ, Hardie A, Smith M, Gaston P, Gibb AP et al (2014) A selected screening programme was less effective in the detection of methicillin-resistant Staphylococcus aureus colonisation in an orthopaedic unit. Int Orthop 38(1):163–167CrossRefPubMed
96.
Dulon M, Peters C, Schablon A, Nienhaus A (2014) MRSA carriage among healthcare workers in non-outbreak settings in Europe and the United States: a systematic review. BMC Infect Dis 3:363CrossRef
97.
Sassmannshausen R, Deurenberg RH, Köck R, Hendrix R, Jurke A, Rossen JWA et al (2016) MRSA Prevalence and Associated Risk Factors among Health-Care Workers in Non-outbreak Situations in the Dutch-German EUREGIO. Front Microbiol
98.
Peters C, Kleinmüller O, Nienhaus A, Schablon A (2018) Prevalence and risk factors of MRSA colonisations: a cross-sectional study among personnel in outpatient care settings in Hamburg, Germany. BMJ Open 16(7):e021204CrossRef
99.
Kyle RG, Wills J, Mahoney C, Hoyle L, Kelly M, Atherton IM (2017) Obesity prevalence among healthcare professionals in England: a cross-sectional study using the Health Survey for England. BMJ Open 7(12):e018498CrossRefPubMedPubMedCentral
100.
Luteijn JM, Hubben GAA, Pechlivanoglou P, Bonten MJ, Postma MJ (2011) Diagnostic accuracy of culture-based and PCR-based detection tests for methicillin-resistant Staphylococcus aureus: a meta-analysis. Clin Microbiol Infect 17(2):146–154CrossRefPubMed
101.
Weatherall M (2017) Systematic review and meta-analysis: tools for the information age. Postgrad Med J 93(1105):696–703CrossRefPubMed
102.
103.
Roth VR, Longpre T, Coyle D, Suh KN, Taljaard M, Muldoon KA et al (2016) Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA). PLOS One 27(7):e0159667CrossRef
104.
Roth VR, Longpre T, Taljaard M, Coyle D, Suh KN, Muldoon KA et al (2016) Universal vs risk factor screening for methicillin-resistant Staphylococcus aureus in a large multicenter tertiary care facility in Canada. Infect Control Hosp Epidemiol 37(1):41–48CrossRefPubMed
105.
Deeny SR, Cooper BS, Cookson B, Hopkins S, Robotham JV (2013) Targeted versus universal screening and decolonization to reduce healthcare-associated meticillin-resistant Staphylococcus aureus infection. J Hosp Infect (1):33–44
106.
107.
Fish R, Kutter E, Wheat G, Blasdel B, Kutateladze M, Kuhl S (2016) Bacteriophage treatment of intransigent Diabetic toe ulcers: a case series. J Wound Care 25(1):S27–S33CrossRef
Metadata
Title
The prevalence of methicillin-resistant Staphylococcus aureus among diabetic patients: a meta-analysis
Authors
Helen J. Stacey
Caitlin S. Clements
Susan C. Welburn
Joshua D. Jones
Publication date
01-08-2019
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 8/2019
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-019-01301-0

Other articles of this Issue 8/2019

Acta Diabetologica 8/2019 Go to the issue

Original Article

Oral glucose effectiveness and metabolic risk in obese children and adolescents

Review Article

Physical activity and risk of diabetic retinopathy: a systematic review and meta-analysis

Letter to the Editor

FreeStyle Libre flash glucose monitoring system in pregnant woman with type 1 diabetes: a focus on accuracy

Original Article

Identification of clinical predictors of diabetic nephropathy and non-diabetic renal disease in Chinese patients with type 2 diabetes, with reference to disease course and outcome

Original Article

Associations of BMI, waist circumference, body fat, and skeletal muscle with type 2 diabetes in adults

Original Article

Accuracy of the 13C-glucose breath test to identify insulin resistance in non-diabetic adults
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits